Is SGOCO Group a Good Fintech Stock to Add to Your Portfolio?

NASDAQ: SGOC | SGOCO Group, Ltd - Ordinary Shares (Cayman Islands) News, Ratings, and Charts

SGOC – Hong Kong-based fintech stock SGOCO Group (SGOC) has garnered triple-digit price gains year-to-date with keen attention from retail traders thanks to social media hype. However, will this relatively new meme stock be able to maintain its momentum amid a potential market correction and ongoing Chinese crackdown on U.S. listings? Read more to find out.

Hong Kong-based fintech company SGOCO Group, Ltd. (SGOC) offers corporate, personal, and mortgage loans in Hong Kong and Australia. As one of the latest meme stocks to attract retail traders, SGOC has gained 951.1% over the past year and 580.7% year-to-date.

Furthermore, SGOC has been one of the best performers in the financial services space over the past month, with 344.6% returns over this period. The stock is frequently discussed on social media platforms Twitter and Reddit.

So, here’s what we think could shape SGOC’s performance in the near term:

U.S. Listing Amid Chinese Crackdown

Hong Kong was brought under the purview of the Chinese government in May 2020. Thus, all Hong Kong-based companies are likely to be affected by the ongoing Chinese crackdown on U.S. listings. The Chinese Communist Party’s Central Committee is fixated on cracking down on illegal securities trading. At the same time, its federal cybersecurity arm has introduced a cybersecurity compliance regime, under which companies are mandated to go through a cybersecurity review before listing in U.S. exchanges.

The threat of potential delisting within the next three years could  cause investors to lose out on their capital locked in China and Hong Kong-based companies. Considering these developments, shares of SGOC have declined 11.4% over the past five days and 14.5% intraday to close yesterday’s trading session at $9.87.

Weak Financials

Despite having a $1.14 billion market capitalization , SGOC has generated $4.29 million in revenues over the past year. The company’s trailing-12-month gross loss came in at $3.05 million, translating to a gross margin of negative 70.95%. Its trailing-12-month net loss and loss per share stood at $67.92 million and $0.69, respectively.

SGOC’s ROE, ROA, and ROTC came in at negative 71.42%, 75.36%, and 3.41%, respectively, over the past 12 months. In addition, the company’s 0.04%  asset turnover ratio is 94.2% lower than the 0.64% industry average.

Stretched Valuation

In terms of trailing-12-month Price/Sales, SGOC is currently trading at 225.57x, which is 5,149.7% higher than the 4.30x industry average. In addition, the stock’s 45.89 trailing-12-month Price/Cash Flow multiple is 109.5% higher than the 21.91 industry average.

SGOC’s 268.28 trailing-12-month EV/Sales ratio compares with a 4.52 industry average.

POWR Ratings Reflect Bleak Prospects

SGOC has an overall D rating, which equates to Sell in our proprietary POWR Ratings system. The POWR Ratings are calculated considering 118 different factors, with each factor weighted to an optimal degree.

The stock has an F grade  for Quality and Value, and a D for Growth. SGOC’s negative profit margins and premium valuation justify the Quality and Value grades. In addition, the company’s revenues declined 16.1% over the past year, in sync with the Growth grade.

Of the 71 stocks in the D-rated China group, SGOC is ranked #66.

Beyond what we have stated above, we have rated SGOC for Momentum, Sentiment, and Stability. Get all SGOC ratings here.

Click here to view the top-rated stocks in the China group.

Bottom Line

The substantial retail investor interest in SGOC has allowed the stock to witness a triple-digit gain over the past couple of months despite the threat of potential delisting amid the Chinese crackdown. Furthermore, as global economic  growth is expected to decelerate given the rapid spread of the COVID-19 Delta variant, the momentum stock might lose its luster soon as investors focus on non-cyclical defensive stocks to hedge against the current market volatility. Thus, we think SGOC is best avoided now. 


SGOC shares were trading at $8.83 per share on Friday afternoon, down $1.04 (-10.54%). Year-to-date, SGOC has gained 508.97%, versus a 18.36% rise in the benchmark S&P 500 index during the same period.


About the Author: Aditi Ganguly


Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do’s and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SGOCGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Investor Alert: Keep Calm and Carry On

The stock market (SPY) took a scary turn on Monday as news of Evergrande culminated in a worldwide sell off. Now with a little time and perspective investors see this was more smoke than actual fire creating a buy the dip event. Why did this happen? And where do stocks head next? Read on for those answers and more below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More SGOCO Group, Ltd - Ordinary Shares (Cayman Islands) (SGOC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SGOC News